Follow the 프로티나 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 프로티나 has recorded 10 insider filings. Market capitalisation: €228.9bn. The latest transaction was filed on 30 April 2026 (Purchase). Among the most active insiders: 최병산. Every trade is free.
10
Insider Decl.
n/a
Thresholds
€618,771
9 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
Buys €618,771n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Protinah es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se especializa en el desarrollo de productos farmacéuticos innovadores.